The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESSO 43 | Impact of malnutrition in gastrointestinal cancer: early detection and intervention are key
Laura Lorenzon, MD, PhD, Policlinico Universitario Agostino Gemelli, Rome, Italy, discusses the significant impact of malnutrition in patients with gastrointestinal (GI) cancer, noting that nearly 30% experience malnutrition. The severity varies between different types of GI cancers, such as colorectal and pancreatic cancers. Early detection and targeted correction of malnutrition can lead to improved therapeutic responses and enhanced survival rates for these patients. This interview took place at the ESSO 43 congress in Antwerp, Belgium.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
